MBIO
$0.89
Market ClosedAs of Mar 17, 8:00 PM UTC
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.89
Potential Upside
5%
Whystock Fair Value$0.93
Price
UndervaluedFair ValueOvervalued
Fundamentals
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.50M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.15
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-418.83%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.03